Search research articles
Contact Us
Filters
Showing results (81-90 of 549) with videos related to
Page
of 55
Sort By:
Molecular Endocrinology (Baltimore, Md.)
|
September 28, 2002
Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine
Grace Flock, Daniel J Drucker
Journal of the American Academy of Child Psychiatry
|
January 1, 1979
First scribbles: the emergence of an ego function
J Drucker, C B Shapiro
Cancer Research
|
July 1, 1993
Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line
X Li, D J Drucker
Journees Annuelles De Diabetologie De L'Hotel-Dieu
|
July 21, 2004
[GLP-2 peptide(glucagon-like peptide-2) controls energetic homeostasis by actions on proliferation and cytoprotection in the gastrointestinal epithelium]
B Yusta, D J Drucker
American Journal of Physiology. Endocrinology and Metabolism
|
January 1, 2009
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
Safina Ali, Daniel J Drucker
Endocrinology
|
June 30, 1998
Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice
L A Scrocchi, D J Drucker
Annual Review of Medicine
|
January 18, 2006
Therapeutic approaches to preserve islet mass in type 2 diabetes
Laurie L Baggio, Daniel J Drucker
The Journal of Nutrition
|
November 11, 2003
Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling
Jennifer L Estall, Daniel J Drucker
Receptors & Channels
|
January 18, 2003
Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors
P L Brubaker, D J Drucker
Diabetologia
|
September 6, 2011
Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
D J Drucker, C F Rosen
Page
of 55
Search research articles
Search
Showing results (81-90 of 549) with videos related to
Sort By:
Page
of 55
Molecular Endocrinology (Baltimore, Md.)
|
September 28, 2002
Pax-2 activates the proglucagon gene promoter but is not essential for proglucagon gene expression or development of proglucagon-producing cell lineages in the murine pancreas or intestine
Grace Flock, Daniel J Drucker
Journal of the American Academy of Child Psychiatry
|
January 1, 1979
First scribbles: the emergence of an ego function
J Drucker, C B Shapiro
Cancer Research
|
July 1, 1993
Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell line
X Li, D J Drucker
Journees Annuelles De Diabetologie De L'Hotel-Dieu
|
July 21, 2004
[GLP-2 peptide(glucagon-like peptide-2) controls energetic homeostasis by actions on proliferation and cytoprotection in the gastrointestinal epithelium]
B Yusta, D J Drucker
American Journal of Physiology. Endocrinology and Metabolism
|
January 1, 2009
Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes
Safina Ali, Daniel J Drucker
Endocrinology
|
June 30, 1998
Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice
L A Scrocchi, D J Drucker
Annual Review of Medicine
|
January 18, 2006
Therapeutic approaches to preserve islet mass in type 2 diabetes
Laurie L Baggio, Daniel J Drucker
The Journal of Nutrition
|
November 11, 2003
Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling
Jennifer L Estall, Daniel J Drucker
Receptors & Channels
|
January 18, 2003
Structure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptors
P L Brubaker, D J Drucker
Diabetologia
|
September 6, 2011
Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
D J Drucker, C F Rosen
Page
of 55